Tenax Therapeutics, Inc. (TENX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Tenax Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Tenax Therapeutics, Inc. (TENX) has returned 31.17% so far this year and 144.12% over the past 12 months. Over the last ten years, TENX has returned -56.42% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jan 2, 1997, TENX's average daily return is +0.12%, while the average monthly return is +1.41%. At this rate, your investment would double in approximately 4.1 years.

Historically, 38% of months were positive and 62% were negative. The best month was Feb 2000 with a return of +582.1%, while the worst month was Jan 2017 at -76.4%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, TENX closed higher 41% of trading days. The best single day was Nov 13, 2023 with a return of +297.4%, while the worst single day was Jan 31, 2017 at -76.4%.

Tenax Therapeutics, Inc. has an annualized alpha of 30.25%, beta of 0.36, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 03, 1997.

• This stock participated in 133.14% of S&P 500 Index downside but only -40.69% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.36 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TENX ranks 90 for risk / return — in the top 90% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Tenax Therapeutics, Inc. (TENX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Tenax Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tenax Therapeutics, Inc. was 100.00%, occurring on Jun 21, 2024. The portfolio has not yet recovered.

The current Tenax Therapeutics, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Tenax Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Tenax Therapeutics, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.